Table 6.
95% Confidence Interval | ||||
---|---|---|---|---|
Hazard Ratio | Lower | Upper | p-value | |
Age (years, median) | 1.02 | 1.00 | 1.05 | 0.05 |
Sex (female) | 0.88 | 0.61 | 1.26 | 0.48 |
Year of diagnosis, median (inter-quartile range) | 0.96 | 0.90 | 1.03 | 0.25 |
CDCC Score (reference: 0) | ||||
1 | 0.85 | 0.55 | 1.31 | 0.46 |
2+ | 1.36 | 0.84 | 2.20 | 0.22 |
Facility type (reference: non-academic) | ||||
Academic/research program | 0.73 | 0.48 | 1.10 | 0.13 |
Insurance type (reference: private) | ||||
Government | 1.46 | 0.95 | 2.25 | 0.09 |
No insurance | 1.60 | 0.37 | 6.90 | 0.53 |
Tumor grade (reference: well differentiated) | ||||
Poorly differentiated | 1.15 | 0.15 | 8.67 | 0.89 |
Undifferentiated | 0.91 | 0.12 | 6.89 | 0.92 |
Adjuvant therapy (reference: none) | ||||
Chemotherapy | 0.89 | 0.63 | 1.26 | 0.50 |